The Future of Addiction Treatment

episode

the goop podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from the goop podcast

An Update on The goop Podcast 1 min · 07 Jul 2026

Joan Nguyen and Sarah Willersdorf on Building With AI: How Two Non-Technical Builders Are Reshaping What's Possible 1h 10m · 30 Jun 2026

Burnout, Boundaries, and the Business of Starting Over 1h 16m · 23 Jun 2026

All episodes from the goop podcast →

Report any issue

Source

Recorded27 Feb 2020

Publisherfeeds.megaphone.fm

Handlerec:465511

Show notes

“Ibogaine made them ready for change,” says researcher Deborah Mash, PhD. Mash has been studying the effects of ibogaine since 1992. A psychedelic compound derived from the bark of a shrub native to western central Africa, ibogaine is being used as a potent addiction disruptor (specifically for opioid use). Ibogaine may have the power to reset opioid tolerance and bypass many of the withdrawal symptoms that people endure when coming off of these drugs. Mash shares the extraordinary stories, people, and challenges behind the science, the studies, and the funding. And: what the future of ibogaine as a treatment for drug addiction might look like. (For more, see The goop Podcast hub.) To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.